Article PDF
References
Lawden MC, Eke T, Degg C, Harding GFA, Wild JM . Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry 1999;67:716–22.
Manuchehri K, Goodman S, Siviter L, Nightingale S . A controlled study of vigabatrin and visual abnormalities. Br J Ophthalmol 2000;84:499–505.
Gross-Tsur V, Banin E, Shahar E, Shalev RS, Lahat E . Visual impairment in children with epilepsy treated with vigabatrin. Ann Neurol 2000;48:60–4.
Hardus P, Verduin WM, Postma G, Stilma JS, Berendschot TTJM, van Veelen CWM . Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin. Br J Ophthalmol 2000;84:788–90.
Daneshvar H, Racette L, Coupland SG, Kertes PJ, Guberman A, Zackon D . Symptomatic and asymptomatic visual loss in patients taking vigabatrin. Ophthalmology 1999;106:1792–8.
Schmidt T, Scmitz B, Jokiel B, et al. Constriction of the visual field in epilepsy patients taking vigabatrin and other antiepileptic drugs: a longitudinal study. Epilepsia 1999;40(Suppl 2):256.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kiratli, H., Türkçüoǧlu, P. Rapid development of visual field defects associated with vigabatrin therapy. Eye 15, 672–674 (2001). https://doi.org/10.1038/eye.2001.214
Issue Date:
DOI: https://doi.org/10.1038/eye.2001.214